Goldman Sachs’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.26M | Buy |
|
|||||
|
2025
Q2 | $750K | Buy |
|
|||||
|
2025
Q1 | $193K | Sell |
|
|||||
|
2024
Q4 | $878K | Buy |
|
|||||
|
2024
Q3 | $535K | Buy |
|
|||||
|
2024
Q2 | $283K | Sell |
|
|||||
|
2024
Q1 | $935K | Sell |
|
|||||
|
2023
Q4 | $3.43M | Buy |
|
|||||
|
2023
Q3 | $1.19M | Sell |
|
|||||
|
2023
Q2 | $2.71M | Buy |
|
|||||
|
2023
Q1 | $2.65M | Sell |
|
|||||
|
2022
Q4 | $4.71M | Buy |
|
|||||
|
2022
Q3 | $3.97M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Buy |
|
|||||
|
2022
Q1 | $1.1M | Sell |
|
|||||
|
2021
Q4 | $1.94M | Buy |
|
|||||
|
2021
Q3 | $376K | Sell |
|
|||||
|
2021
Q2 | $683K | Buy |
|
|||||
|
2021
Q1 | $942K | Buy |
|